Genentech and Google DeepMind unveil PerturbME for discovering unknown biology

AllThingsApx · x · 2026-08-22

Genentech, in collaboration with Google DeepMind, the Broad Institute, and Stanford, introduced PerturbME, a framework designed to scale the discovery of unknown biology and mechanisms. It combines GDM's Co-Scientist agent with a sample-efficient, genome-wide, multimodal perturbation framework. This technique allows selective sequencing of informative cancer cells while Co-Scientist generates mechanistic hypotheses. Insights from this work could advance next-generation cancer therapies, including protein binders, mRNA vaccines, and CAR-T cells. A preprint with data and code has been released.

Original post →

More from Research

Research channel →